Neurosurgery Blog
Mendelian randomization provides support for obesity as a risk factor for meningioma
Sci Rep. 2019; 9: 309. Published online 2019 Jan 22. doi: 10.1038/s41598-018-36186-6 PMCID: PMC6343031 PMID: 30670737 Mendelian randomization provides support for obesity as a risk factor for meningioma Hannah Takahashi,#1 Alex J. Cornish,#1 Amit Sud,1 Philip J. Law,1 Linden Disney-Hogg,1 Lisa Calvocoressi,2 Lingeng Lu,2 Helen...
Trends in intracranial meningioma incidence in the United States, 2004‐2015
Cancer Med. 2019 Oct; 8(14): 6458–6467. Published online 2019 Sep 1. doi: 10.1002/cam4.2516 PMCID: PMC6797634 PMID: 31475482 Trends in intracranial meningioma incidence in the United States, 2004‐2015 Dong‐Dong Lin, 1 Jia‐Liang Lin, 2 Xiang‐Yang Deng, 1 Wei Li, 1 Dan‐Dong Li, 1 Bo Yin, 1 Jian Lin, 1 Nu Zhang, 1 and Han‐Song Sheng 1 Author...
Ser neurocirurgião é difícil ?
Recebo várias perguntas no YouTube neurocirurgiabr sobre minha rotina e o stress de lidar com doenças graves. Perguntas como: ⁃ Como você lida com pessoas com doenças tão graves? Isso não te deixa para...
O Cérebro e a Serra
O Cérebro e a Serra Autor: Júlio Pereira feat paciente artista 👩🎨 Um artista viu a sua neurocirurgia e comentou: Vi minha cirurgia que o Sr. Mandou Nós sempre filmamos e mandamos Achei lindo...
Should Doctors Have Tattoos? (Medscape)
October 23, 2019Siobhan HarrisDISCLOSURES Can doctors have any tattoo they like? Are they a valid form of self-expression for doctors just like anyone else, or are there special rules for medics? Read more: https://www.medscape.com/viewarticle/920155?src=soc_fb_191110_mscpedt_news_mdscp_tattoo%20&faf=1...
Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials
Abstract Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trial. Shuang Bai et al https://jnnp.bmj.com/content/early/2019/08/29/jnnp-2019-320912 Objectives To systematically review the efficacy and...
Advances in the Treatment of Metastatic Spine Tumors: The Future Is Not What It Used to BeAdvances in the Treatment of Metastatic Spine Tumors: The Future Is Not What It Used to Be
Advances in the Treatment of Metastatic Spine Tumors: The Future Is Not What It Used to Be Ilya Laufer et al. J Neurosurg Spine. 2019 Abstract An improved understanding of tumor biology, the ability...
Ácido Tranexâmico no Traumatismo Cranioencefálico (CRASH-3 Trial): já é hora de atualizar nossa conduta?
Por Davi J. Fontoura Solla, Residente em Neurocirugia – Hospital das Clínicas da Faculdade de Medicina da USP Foi publicado na semana passada no The Lancet o estudo CRASH-3 1, um ensaio clínico multicêntrico, randomizado e...